PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 25520194-6 2015 We show that RECQL5, but not BLM, conferred resistance to mitomycin C (MMC, an interstrand crosslinker) and camptothecin (CPT, a type 1 topoisomerase inhibitor) in FANCB-defective cells. Camptothecin 108-120 RecQ like helicase 5 Homo sapiens 13-19 26959889-2 2016 The five human RecQ helicases, RECQL1, Bloom, WRN, RECQL4 and RECQL5 play critical roles in DNA repair and cell survival after treatment with the anticancer drug camptothecin (CPT). Camptothecin 162-174 RecQ like helicase 5 Homo sapiens 62-68 26959889-2 2016 The five human RecQ helicases, RECQL1, Bloom, WRN, RECQL4 and RECQL5 play critical roles in DNA repair and cell survival after treatment with the anticancer drug camptothecin (CPT). Camptothecin 176-179 RecQ like helicase 5 Homo sapiens 62-68 21278449-5 2011 In particular, current studies have revealed the presence of a novel Recql5/RECQL5-dependent mechanism for suppressing replication fork collapse in response to global replication fork stalling following exposure to camptothecin (CPT), a topoisomerase I inhibitor, and a potent inhibitor of DNA replication. Camptothecin 215-227 RecQ like helicase 5 Homo sapiens 69-75 21278449-5 2011 In particular, current studies have revealed the presence of a novel Recql5/RECQL5-dependent mechanism for suppressing replication fork collapse in response to global replication fork stalling following exposure to camptothecin (CPT), a topoisomerase I inhibitor, and a potent inhibitor of DNA replication. Camptothecin 215-227 RecQ like helicase 5 Homo sapiens 76-82 21278449-5 2011 In particular, current studies have revealed the presence of a novel Recql5/RECQL5-dependent mechanism for suppressing replication fork collapse in response to global replication fork stalling following exposure to camptothecin (CPT), a topoisomerase I inhibitor, and a potent inhibitor of DNA replication. Camptothecin 229-232 RecQ like helicase 5 Homo sapiens 69-75 21278449-5 2011 In particular, current studies have revealed the presence of a novel Recql5/RECQL5-dependent mechanism for suppressing replication fork collapse in response to global replication fork stalling following exposure to camptothecin (CPT), a topoisomerase I inhibitor, and a potent inhibitor of DNA replication. Camptothecin 229-232 RecQ like helicase 5 Homo sapiens 76-82 20231364-5 2010 Fully functional RecQL5 requires both helicase activity and associations with the initiation polymerase, because mutants lacking either activity are partially defective in the suppression of sister chromatid exchange and resistance to camptothecin-induced DNA damage, and mutants lacking both activities are completely defective. Camptothecin 235-247 RecQ like helicase 5 Homo sapiens 17-23 22645136-3 2012 Here, we identified a BRC repeat variant, named BRCv, in the RECQL5 helicase, which possesses anti-recombinase activity in vitro and suppresses HR and promotes cellular resistance to camptothecin-induced replication stress in vivo. Camptothecin 183-195 RecQ like helicase 5 Homo sapiens 61-67 22645136-5 2012 Mutations of either motif compromised functions of RECQL5, including association with RAD51, inhibition of RAD51-mediated D-loop formation, suppression of sister chromatid exchange, and resistance to camptothecin-induced replication stress. Camptothecin 200-212 RecQ like helicase 5 Homo sapiens 51-57 21210765-0 2011 RECQL5 is an important determinant for camptothecin tolerance in human colorectal cancer cells. Camptothecin 39-51 RecQ like helicase 5 Homo sapiens 0-6